About Taizhou Central Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Taizhou Central Hospital
During the past decade, Taizhou Central Hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
CAmpto-CISplatine Plus Radiotherapy in Advanced Cervix Cancer : Search of Tolerated Maximum Dose of Campto
2002-11-01
2005-11-01
Completed
15
Study of Sentinel Lymph Node Assessment Following Previous Surgical Biopsy for Early Breast Cancer
2006-03-01
2012-03-01
Completed
203
Sentinel Lymph Node Technique in Multifocal Breast Cancer
2006-03-01
2008-09-01
Completed
216
Phase II Two-step Radioimmunotherapy Clinical Study in Medullary Thyroid Carcinoma
2004-05-01
2011-01-01
Completed
Phase II Study , Association of Cisplatine Topotecan and Cetuximab in Patients Whith Late or in Progress Epithelial Cancer of the Cervix
2007-04-01
2008-09-01
Terminated
44
Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer
2010-07-01
2020-12-31
Completed
408
Radiotherapy - Anastrazole Concomitant : Evaluation of the Side Effects
2005-08-01
2016-01-01
Completed
490
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
2011-01-15
2024-03-07
Active, not recruiting
5,083
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Taizhou Central Hospital" #1 sponsor was "Zhejiang Cancer Hospital" with 2 trials, followed by "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 1 trials
sponsored, "Shanghai Jiao Tong University School of Medicine" with 1 trials sponsored, "Shenyang Northern Hospital" with 1 trials sponsored and "Taizhou Hospital"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Taizhou Central Hospital"
#1 collaborator was "Taizhou Cancer Hospital" with 1 trials as a collaborator and "Taizhou Enze Medical Center (Group) Enze Hospital" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Taizhou Central Hospital
According to Clinical.Site data, the most researched conditions in "Taizhou Central Hospital" are
"Breast Neoplasm" (1 trials), "Camrelizumab" (1 trials), "Cervical Cancer" (1 trials), "Nasopharyngeal Carcinoma" (1 trials) and "Oncolytic Virotherapy" (1 trials). Many other conditions were trialed in "Taizhou Central Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Taizhou Central Hospital
Most popular intervention types in "Taizhou Central Hospital" are "Drug" (5 trials) and "Radiation" (2 trials). Other intervention types were less common.
The name of intervention was led by "Anlotinib" (1 trials), "Anlotinib(blank)" (1 trials), "Bivalirudin" (1 trials), "Chemotherapy" (1 trials) and "Conventional dose" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Taizhou Central Hospital
The vast majority of trials in "Taizhou Central Hospital" are
3 trials for "All" genders and 3 trials for "Female" genders.
Clinical Trials Status at Taizhou Central Hospital
Currently, there are NaN active trials in "Taizhou Central Hospital".
1 are not yet recruiting,
4 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Taizhou Central Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Taizhou Central Hospital, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".